Laboratorios Grossman S.A. is a Mexican pharmaceutical manufacturer incorporated in 1953 and headquartered in Mexico City (Coyoacan). The company manufactures and markets a broad portfolio of pharmaceutical products, including injectables, tablets, and suspensions across multiple therapeutic categories. It operates as a wholly owned subsidiary of Bausch Health Companies Inc., a global diversified pharmaceutical company, and is listed among Bausch Health's Mexican subsidiaries. The company employs approximately 600 people and specializes in pharmaceutical preparation manufacturing for the Mexican market.
| Import | Export |
|---|---|
|
Trade Records
305
|
Trade Records
92
|
|
Suppliers
25
|
Buyers
4
|
|
Latest Import Date
2026-06
|
Latest Export Date
2026-06
|
According to Topease's global trade data, LABORATORIOS GROSSMAN S. A. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the LABORATORIOS GROSSMAN S. A. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, LABORATORIOS GROSSMAN S. A. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore LABORATORIOS GROSSMAN S. A.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| BAUSCH HEALTH IRELAND LTD. | LABORATORIOS GROSSMAN S. A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| CATALENT ARGENTINA SAIYC | LABORATORIOS GROSSMAN S. A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| BIOSINT S P A | LABORATORIOS GROSSMAN S. A. | 2923 | 24 | $186,500 | 3,420 | Los Angeles |
| ROEMMERS S A C I F | LABORATORIOS GROSSMAN S. A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| AMERICAN LABORATORIES LLC | LABORATORIOS GROSSMAN S. A. | 3001 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into LABORATORIOS GROSSMAN S. A.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| BAUSCH HEALTH IRELAND LTD. | LABORATORIOS GROSSMAN S. A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| HUMAX PHARMACEUTICAL S.A. | LABORATORIOS GROSSMAN S. A. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| LABORATORIOS GROSSMAN S. A. | LABORATORIOS GROSSMAN S. A. | 2907 | 24 | $186,500 | 3,420 | Los Angeles |
| LABORATORIOS GROSSMAN | LABORATORIOS GROSSMAN S. A. | 2907 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore LABORATORIOS GROSSMAN S. A.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access LABORATORIOS GROSSMAN S. A.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.